Sterling Biotech Ltd
Fortune 500 2012
+ 2 More
+ 2 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Fortune 500 India
#447(2012)
#402(2011)
#339(2010)
#447(2012)#402(2011)#339(2010)
Financial Data 2023
Revenue
6,768
(INR Cr)
Net Operating Income
433
(INR Cr)
Assets
903
(INR Cr)
Profit
5,989
(INR Cr)
Net Worth
899
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 6768 1507.2% | 421 -1.0% | 425 19.5% | 356 3.4% | 344 -3.7% | 358 -42.5% | 622 -24.5% | 823 18.4% | 695 -20.6% | 875 -51.9% | 1820 5.8% | 1721 2.4% | 1680 41.8% | 1185 - |
| Net Operating Income (INR Cr) | 433 5.72% | 410 19.63% | 343 -0.89% | 346 0.00% | 352 -4.37% | 368 -29.69% | 524 -21.43% | 667 -7.12% | 718 -13.98% | 835 -49.77% | 1662 2.81% | 1617 12.41% | 1438 22.05% | 1178 29.37% |
| Profit (INR Cr) | 5989 - | -295 - | -844 - | -432 - | -1005 - | -412 - | -450 - | -458 - | -401 - | -350 - | 19 -86.8% | 145 -38.3% | 235 6.9% | 220 - |
| Assets (INR Cr) | 903 -61.4% | 2337 -5.2% | 2466 -27.0% | 3378 -56.5% | 7769 -5.6% | 8225 -0.1% | 8231 15.2% | 7143 -2.7% | 7338 7.0% | 6861 1.7% | 6746 8.5% | 6215 20.4% | 5161 17.4% | 4398 - |
| Net Worth (INR Cr) | 899 -115.7% | -5733 5.4% | -5439 18.3% | -4596 0.0% | 276 -78.4% | 1276 -23.3% | 1664 60.4% | 1037 -29.4% | 1470 -21.4% | 1871 -24.9% | 2491 0.8% | 2471 19.4% | 2070 19.8% | 1728 33.8% |
| Employee Cost (INR Cr) | 43 4.7% | 41 0.9% | 41 2.7% | 40 -31.5% | 58 7.4% | 54 -17.7% | 66 28.0% | 52 -4.7% | 54 1.0% | 54 8.7% | 49 15.8% | 43 7.8% | 40 13.7% | 35 - |
| Interest Cost (INR Cr) | 0 | 2 | 0 | 0 | 440 | 370 | 415 | 470 | 438 | 412 | 270 | 230 | 149 | 59 |
| Cash & Bank Balance (INR Cr) | 165 | 198 | 110 | 82 | 13 | 17 | 17 | 18 | 17 | 18 | 22 | 158 | 129 | 102 |
| Total Debt (INR Cr) | 0 | 6086 | 5921 | 5990 | 5514 | 5036 | 6568 | 4599 | 5868 | 4990 | 4255 | 3744 | 3091 | 2670 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 88.5% | - | - | - | - | - | - | - | - | - | 1.1% | 8.5% | 14.0% | 18.6% |
| Profit As % Of Assets | 663.3% | - | - | - | - | - | - | - | - | - | 0.3% | 2.3% | 4.6% | 5.0% |
| Profit As % Of Networth | 666.4% | - | - | - | - | - | - | - | - | - | 0.8% | 5.9% | 11.4% | 12.7% |
| Interest Cost to EBITDA % | 0.4% | - | 0.4% | - | - | 2941.9% | 643.6% | 587.6% | 462.3% | 281.7% | 50.0% | 36.4% | 29.6% | 12.1% |
| Debt to Equity Ratio | - | - | - | - | 19.99 | 3.95 | 3.95 | 4.43 | 3.99 | 2.67 | 1.71 | 1.52 | 1.49 | 1.54 |
| RONW | 4.5% | - | - | - | - | - | - | - | - | - | 4.7% | 8.3% | 9.9% | 14.6% |
| ROCE | -4.4% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -2.2% | -1.6% | 6.1% | 9.0% | 8.2% | 10.3% |